54
Views
15
CrossRef citations to date
0
Altmetric
Antimicrobial Chemotherapy

Antibiotic Prophylaxis in Hernia Repair and Breast Surgery: A Prospective Randomized Study Comparing Piperacillin/Tazobactam Versus Placebo

Pages 278-289 | Published online: 18 Jul 2013

References

  • Smyth ET, Emmerson AM. Surgical site infection sur-veillance. J Hosp Infect 2000; 45: 173–184.
  • Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 2004; 38: 1706–1715.
  • Platt R, Zaleznik DF, Hopkins CC, et al. Perioperative antibiotic prophylaxis for herniorrhaphy and breast surgery. N Engl J Med 1990; 322: 153–160.
  • Platt R, Zucker JR, Zaleznik DF, et al. Prophylaxis against wound infection following herniorrhaphy or breast surgery. J Infect Dis 1992; 166: 556–560.
  • Lewis RT, Weigand FM, Mamazza J, Lloyd-Smith W, Tataryn D. Should antibiotic prophylaxis be used routinely in clean surgical procedures: a tentative yes. Surgery 1995; 118: 742–746.
  • Leaper DJ. Use of antibiotic prophylaxis in clean non-implant wounds. J Antimicrob Chemother 1998; 41: 501–504.
  • Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guidelines for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1999; 20: 250–278.
  • Giacometti A, Cirioni O, Schimizzi AM, et al. Epidemiology and microbiology of surgical wound infections. J Clin Microbiol 2000; 38: 918–922.
  • Vilar-Compte D, Jacquemin B, Robles-Vidal C, Volkow P. Surgical site infections in breast surgery: case-control study. World J Surg 2004; 28: 242–246.
  • Perry CM, Markham A. Piperacillin/tazobactam: an updated review of its use in the treatment of bacterial infec-tions. Drugs 1999; 57: 805–843.
  • Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16: 128–140.
  • National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests: approved standard M2-A6. Villanova, Pennsylvania, 1997.
  • Celdran A, Frieyro O, de la Pinta JC, Souto JL, Esteban J, Rubio JM, Senaris JF. The role of antibiotic pro-phylaxis on wound infection after mesh hernia repair under local anesthesia on an ambulatory basis. Hernia. 2004; 8: 20–22.
  • Gupta R, Sinnett D, Carpenter R, Preece PE, Royle GT. Antibiotic prophylaxis for post-operative wound infection in clean elective breast surgery. Eur J Surg Oncol 2000; 26: 363–366.
  • Sanchez-Manuel FJ, Seco-Gil JL and Cochrane Colorectal Cancer Group. Antibiotic prophylaxis for hernia repair. Cochrane Database of Systematic Reviews(C D003769) http://search.epnet.com/login.aspx?direct=true&db=chh&an=CD003769
  • Manian FA, Meyer L. Comprehensive surveillance of surgical wound infections in outpatient and inpatient. Infect Control Hosp Epidemiol 1990; 11: 515–520.
  • Olson MM, Lee JT Jr. Continuous, 10-year wound infection surveillance. Results, advantages, and unanswered questions. Arch Surg 1990; 125: 794–803.
  • Bailey IS, Karran SE, Toyn K, Brough P, Ranaboldo C, Karran SJ. Community surveillance of complications after her-nia surgery. BMJ 1992; 304: 469–471.
  • Esposito S, Novelli A, de Lalla F. Antibiotic prophylaxis in surgery: news and controversies. Infez Med 2002; 10: 131–144.
  • Esposito S, Capuano A, Noviello S, et al. Modification of patients' endogenous bacterial flora during hospitalization in a large teaching hospital in Naples. J Chemother 2003; 15: 568–573.
  • Kernodle DS, Classen DC, Stratton CW, Kaiser AB. Association of borderline oxacillin-susceptible strains of Staphylococcus aureus with surgical wound infections. J Clin Microbiol 1998; 36: 219–222.
  • Verbist L, Verhaegen J, Wouters C, Vandenhoven G. Comparative activity of piperacillin/tazobactam against 5625 isolates from hospitalised patients. Multicentre Study Group. J Antimicrob Chemother 1996; 37: 285–293.
  • Doern GV, Jones RN, Pfaller MA, Erwin M, Ramirez-Rhonda C. Multicenter evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents in Puerto Rico. The Puerto Rico Antimicrobial Resistance Study Group.Diagn Microbiol Infect Dis 1998; 30: 113–119.
  • Dembry LM, Roberts JC, Schock KD, Marino SP, Farrel PA, Andriole VT. Comparison of in vitro activity of trovafloxacin against gram-positive and gram-negative organ-isms with quinolones and beta-lactam antimicrobial agents. Diagn Microbiol Infect Dis 1998; 31: 301–311.
  • Pallares R, Pujol M, Pena C, Ariza J, Martin R, Gudiol F. Cephalosporins as risk factor for nosocomial Enterococcus faecalis bacteremia. A matched case-control study. Arch Intern Med 1993; 153: 1581–1586
  • Terpstra S, Noordhoek GT, Voesten HG, Hendriks B, Degener JE. Rapid emergence of resistant coagulase-negative staphylococci on the skin after antibiotic prophylaxis. J Hosp Infect 1999; 43: 195–202.
  • Edlund C, Stark C, Nord CE. The relationship between an increase in beta-lactamase activity after oral administration of three new cephalosporins and protection against intestinal ecological disturbances. J Antimicrob Chemother 1994; 34: 127–138.
  • Archer GL, Armstrong BC. Alteration of staphylococcal flora in cardiac surgery patients receiving antibiotic prophylax-is. J Infect Dis 1983; 147: 642–649.
  • Kernodle DS, Barg NL, Kaiser AB. Low-level coloniza-tion of hospitalized patients with methicillin-resistant coagu-lase-negative staphylococci and emergence of the organisms during surgical antimicrobial prophylaxis. Antimicrob Agents Chemother 1988; 32: 202–208.
  • Edgeworth JD, Treacher DF, Eykyn SJ. A 25-year study of nosocomial bacteremia in an adult intensive care unit. Crit Care Med 1999; 27: 1421-1428.
  • Rice LB, Willey SH, Papanicolaou GA, et al. Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic-care facility. Antimicrob Agents Chemother 1990; 34: 2193–2199.
  • Rice LB, Eckstein EC, DeVente J, Shlaes DM. Ceftazidime-resistant Klebsiella pneumoniae isolates recov-ered at the Cleveland Department of Veterans Affairs Medical Center. Clin Infect Dis 1996; 23: 118–124.
  • Cruse PJ, Foord R. A five-year prospective study of 23649 surgical wounds. Arch Surg 1973; 107: 206–210.
  • Gordon SM, Serkey JM, Barr C, Cosgrove D, Potts W. The relationship between glycosylated hemoglobin (HgAlc) levels and postoperative infections in patients undergoing pri-mary coronary artery bypass surgery (CABG). Infect Control Hosp Epidemiol 1997; 18: 29.
  • Zerr KJ, Furnary AP, Grunkemeier GL, Bookin S, Kanhere V, Starr A. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg 1997; 63: 356–361.
  • Terranova A. The effects of diabetes mellitus on wound healing. Plast Surg Nurs 1991; 11: 20–25.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.